Pregnancy and multiple sclerosis: the initial results from a Brazilian database Gravidez e esclerose múltipla: resultados preliminares de base de dados Brasileira

Pregnancy and multiple sclerosis: the initial results from a Brazilian database Gravidez e esclerose múltipla: resultados preliminares de base de dados Brasileira

PURPOSE: Pregnancy management poses an extra challenge to physicians and their multiple sclerosis (MS) patients. There are few papers reporting databases on the subject. METHOD: Brazilian database from nine MS clinical and research units, with complete data on 47 pregnant women (49 pregnancies). RES...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yara Dadalti Fragoso, Alessandro Finkelsztejn, Elizabeth Regina Comini-Frota, Paulo Diniz da Gama, Ansderson Kuntz Grzesiuk, Jussara Mathias Netto Khouri, Soniza Vieira Alves-Leon, Rogério de Rizo Morales, Marco Aurélio Lana-Peixoto, Cristiane Franklin da Rocha
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações 2009-09-01
Series:	Arquivos de Neuro-Psiquiatria
Subjects:	esclerose múltipla gravidez prematuridade baixo peso complicações obstétricas interferon beta, acetato de glatirâmer multiple sclerosis pregnancy prematurity low birth weight obstetric complications interferon beta glatiramer acetate
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2009000400015
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical response to interferon beta and glatiramer acetate in multiple sclerosis patients: a Brazilian cohort
by: Valéria Coelho Santa Rita Pereira, et al.
Published: (2012-10-01)

Patients’ satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
by: Caroline Vieira Spessotto, et al.
Published: (2016-08-01)

Tolerability, adverse events and compliance to glatiramer acetate in 28 patients with multiple sclerosis using the drug continuously for at least six months Tolerabilidade, eventos adversos e aderência ao acetato de glatiramer em 28 pacientes com esclerose múltipla usando a droga continuamente por pelo menos seis meses
by: Ana Patricia Perez Fiore, et al.
Published: (2005-09-01)

Interferon beta 1-a na esclerose múltipla: experiência de um ano em 62 pacientes
by: CHARLES P. TILBERY, et al.
Published: (2000-06-01)

Fênomeno de Raynaud grave associado a terapia com interferon-beta para esclerose múltipla: relato de caso
by: BORIS AFONSO CRUZ, et al.
Published: (2000-06-01)

Glatiramer–diclofenac nanocomplex enhances remyelination in a mouse model of multiple sclerosis
by: Bander M. Aldhabi, et al.
Published: (2025-05-01)

Interferon beta-1a in chronic inflammatory demyelinating polyneuropathy: case report Interferon beta en polineuropatía crónica inflamatoria desmienlinizante: caso clínico
by: Andrés Maria Villa, et al.
Published: (2004-09-01)

HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysisResearch in context
by: Brian C. Zhang, et al.
Published: (2025-08-01)

Slow Subcutaneous Release of Glatiramer Acetate or CD40-Targeting Peptide KGYY<sub>6</sub> Is More Advantageous in Treating Ongoing Experimental Autoimmune Encephalomyelitis
by: Gisela M. Vaitaitis, et al.
Published: (2024-11-01)

Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works
by: Amélia Mendes, et al.
Published: (2011-06-01)

Cerebrospinal fluid type I interferon and cytokine profiles in enteroviral meningitis according to the presence or absence of pleocytosis
by: Kyung Yeon Lee, et al.
Published: (2021-05-01)

Interferon-β and interleukin-6 exert opposing effects on Foxp3 acetylation to control regulatory T cell induction
by: Mehek Ningoo, et al.
Published: (2025-05-01)

Interferon Beta: Analysis of Information on Adverse Reactions and Evaluation of Possibility of Signal Identification
by: K. E. Zatolochina, et al.
Published: (2019-06-01)

Interferon beta-1a-induced depression and suicidal ideation in multiple sclerosis
by: Marco Aurélio Lana-Peixoto, et al.
Published: (2002-09-01)

EFFICACY AND SAFETY OF A NEW COMBINED MEDICATION WITH RECOMBINANT INTERFERON AND BETAMETHASONE IN THE TREATMENT OF HAY FEVER DURING PERIODS OF EXACERBATION
by: A. A. Ryabtseva, et al.
Published: (2016-09-01)

Study the expression level of beta 2 microglobulin gene on hepatitis C patients before and after treatment with interferon
by: Baghdad Science Journal
Published: (2012-09-01)

Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2022-10-01)

Quercetin Improves the Histopathological Changes of Liver Caused by Interferon Beta 1b-induced Liver Injury
by: Noor kamel Obead, et al.
Published: (2025-05-01)

Interferon‐beta signaling in retinal mononuclear phagocytes attenuates pathological neovascularization
by: Anika Lückoff, et al.
Published: (2016-05-01)

Role of Defective Interfering Particles in Complement-Mediated Lysis of Parainfluenza Virus-Infected Cells
by: Jenna R. Aquino, et al.
Published: (2025-03-01)

Bifidobacterium longum subsp. infantis CCFM1269 promotes intestinal barrier and release of IFN-β through TLR4-TRIF dependent way in growing mice
by: Mengfan Ding, et al.
Published: (2025-01-01)

Interferon status at the women with recurrent genital herpes in combined liposomal RNA treatment
by: A. Sh. Makhmutkhodzhayev, et al.
Published: (2012-06-01)

The effectiveness of Interferon-Ophthalmo, an antiviral and immunotropic drug, in the treatment of adenoviral ophthalmic infections
by: E. V. Yani, et al.
Published: (2023-03-01)

Effects of Different Doses of Quercetin on Apoptotic Markers and Liver Enzymes in Liver Injury Induced by Interferon Beta-1b (Betaferon) in Male Rats in Comparison with Silymarin
by: Noor Kamel Obead, et al.
Published: (2025-06-01)

Genetic Polymorphism of Interferon-Gamma +874T/A as a Risk Factor for Pulmonary Tuberculosis in Cirebon, Indonesia
by: Allain Umadela Deuxawalu Kiteswara, et al.
Published: (2024-11-01)

Experiences of women who faced a pregnancy between 35 and 45 years of age / Experiencias de mulheres ao vivenciarem uma gravidez entre 35 e 45 anos de idade
by: Maria Érica Leite Tavares, et al.
Published: (2021-09-01)

Experiences of women who faced a pregnancy between 35 and 45 years of age / Experiencias de mulheres ao vivenciarem uma gravidez entre 35 e 45 anos de idade
by: Maria Érica Leite Tavares, et al.
Published: (2021-09-01)

IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
by: Sophia Davidson, et al.
Published: (2016-08-01)

ADMINISTRATION CRITERIA FOR INTERFERON-BASED DRUGS AND ITS INDUCERS IN ACUTE RESPIRATORY INFECTIONS IN CHILDREN
by: E. G. Golovacheva, et al.
Published: (2014-07-01)

The expression of interferon-stimulated genes (interferon “signature”) in patients with rheumatoid arthritis (Preliminary results)
by: A. S. Avdeeva, et al.
Published: (2021-01-01)

Deletion of the Human Cytomegalovirus US2 to US11 Gene Family Members Impairs the Type-I Interferon Response
by: Inessa Penner, et al.
Published: (2025-03-01)

Exploring the hair follicle immune privilege state in nonsegmental vitiligo
by: Tag Anbar, et al.
Published: (2025-05-01)

ID238 Monitoramento do uso da desmopressina para o tratamento do diabetes insipido no SUS
by: Samara Helena de Carvalho, et al.
Published: (2024-11-01)

COMPARTIMENTACIÓN INTRACELULAR DEL ACETATO EN NEURONAS DURANTE LA PRELACTANCIA
by: B. Barrios-Socha, et al.
Published: (2006-06-01)

ACTIVATION OF SYNTHESIS OF ENDOGENOUS INTERFERON (REVIEW)
by: V. V. Poloskov, et al.
Published: (2019-01-01)

Efficacy and safety of the type I interferon receptor inhibitor anifrolumab in patients with systemic lupus erythematosus (results of a 6-month study)
by: T. M. Reshetnyak, et al.
Published: (2024-04-01)

Portrait of a patient with systemic lupus erythematosus for the prescription of the type I interferon inhibitor anifrolumab
by: T. M. Reshetnyak, et al.
Published: (2023-12-01)

Rapid achievement of low disease activity during the use of a type I interferon inhibitor in a patient with torpid systemic lupus erythematosus (case report)
by: A. A. Baranov, et al.
Published: (2024-06-01)

New approaches to the therapy of infectious mononucleosis
by: Yu. G. Pritulina, et al.
Published: (2021-06-01)

Treatment of neuromyelitis optica: an evidence based review
by: Douglas Sato, et al.
Published: (2012-01-01)